Tyra Biosciences, Inc.
Alan Fuhrman (Chief Financial Officer) reports TYRA insider transactions
About this filing
Tyra Biosciences, Inc. (TYRA) filed Form 4 (insider transaction) with the SEC on Sep 17, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Alan Fuhrman · Chief Financial Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | A · grantFootnotes F1, F2 | +951 | $9.13 | $8,681.68 | 37,115 | Direct |
Footnotes
- F1 These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.
- F2 Includes restricted stock units.
More TYRA filings
- SC 13G/A
Filed Oct 27, 2026
- SC 13G
Filed Sep 21, 2026
- 4
Filed Sep 17, 2026
- 4
Filed Sep 17, 2026
- SC 13D/A
Filed Sep 17, 2026
- 4
Filed Sep 17, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.